AudiologyOnline Phone: 800-753-2160

InnoCaption - Connected - July 2024

Bio-logic Systems Names Robert Sciote Vice President Hearing Business North


MUNDELEIN, Ill., /PRNewswire/ -- Bio-logic Systems Corp. (Nasdaq: BLSC), a designer and marketer of computerized medical electrodiagnostic equipment announced today that Mr. Robert Sciote has been appointed to fill the newly created position of Vice President - Hearing Business North America. Sciote, a 13-year veteran of the medical equipment industry, will be responsible for all business aspects of the company's fast growing hearing screening, diagnostic and supplies businesses. His appointment was effective May 14, 2001, and he will report directly to Roderick G. Johnson, president and chief operating officer.

Prior to joining Bio-logic, Sciote spent two years in a key management position at Beltone Electronics Corporation, a leading hearing aid manufacturer based in Chicago, which was acquired by GN Great Nordic in 2000. During his tenure at Beltone, he served as Area Vice President, where he was responsible for managing a 16-state region. From 1996 to 1999 he served as Director of Sales for the NeuroCare Group, a $33 million manufacturer of medical technology products targeted at the neurosurgical market, founded by Johnson, and later acquired by Integra LifeSciences Corp. in 1999. Prior to that, Sciote progressed through several key sales, sales training, marketing and major account positions for Johnson & Johnson's Ethicon Endo-Surgery company. Sciote graduated with a BA degree from Geneva College.

Commenting on the announcement, Johnson stated, 'Bob brings a proven track record and significant experience in developing customer relationships and winning organizations in environments of complex medical equipment and disposables for neurosurgery, laporoscopic surgery and most recently hearing aids. He brings a unique skill set to Bio-logic, which complements the depth and experience of our current senior management team.

Johnson added, 'The creation of this new position reflects Bio-logic's commitment to growing the company's Hearing unit. As Vice President, Bob will assume responsibility for developing strategies to drive a sustainable leadership position for Bio-logic Systems Corp. in the US and Canada. He will lead both the longstanding dealer network and the newly established field sales force selling our screening products in key states, as well as the expanding sales, marketing and support team for hearing products at headquarters.'

Sciote commented, 'I am excited about the opportunity this new role presents. Bio-logic is a growing company in a marketplace where there are new opportunities every day. Today, customers and researchers call on Bio-logic, seeking our insight in the field of hearing screening and diagnostics technology. We help them make better decisions, from large-scale deployment of hardware and software to individual placements in clinics and hospitals. Bio-logic is a leader in this market and I'm excited about what the future holds.'

Bio-logic Systems Corp., headquartered in Mundelein, IL, designs, develops, assembles and markets computer-based electrodiagnostic systems for use by hospitals, clinics, universities and physicians. The systems conduct tests that are typically used by medical practitioners to aid in the diagnosis of certain neurological disorders, brain disorders and tumors, and sensory disorders, including audiological and hearing screening and diagnosis.

Except for descriptions of historical facts, this release contains forward-looking statements that involve known and unknown risks, which may cause the company's actual results in the future to differ materially from those currently anticipated. These results include, among others, fluctuations in sales and operating results; the company's ability to recruit and train the necessary number of sales representatives and installation technicians; risks associated with international operations including monetary crisis; regulatory, competitive and contractual risks; the effects of economic conditions; and the availability of capital to finance planned growth, as well as other risks detailed from time to time in the company 's filings with the Securities and Exchange Commission.

Signia Xperience - July 2024

Our site uses cookies to improve your experience. By using our site, you agree to our Privacy Policy.